Xanthine Oxido-Reductase, Free Radicals and Cardiovascular Disease. A Critical Review

Purinergic Signaling during Inflammation

(2012) Holger K. Eltzschig et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction

(2012) Eswar Krishnan et al.   ARTHRITIS RESEARCH & THERAPY

Latest evidence on gout management: what the clinician needs to know

(2012) Christopher M. Burns et al.   Therapeutic Advances in Chronic Disease

Allopurinol as a Cardiovascular Drug

(2011) Anita Kelkar et al.   Cardiology in Review

Gout, Allopurinol Use, and Heart Failure Outcomes

(2010) George Thanassoulis   ARCHIVES OF INTERNAL MEDICINE

Attenuated variants of Lesch-Nyhan disease

(2010) H. A. Jinnah et al.   BRAIN

Phenotype and Genotype Characterization of Adenine Phosphoribosyltransferase Deficiency

(2010) G. Bollee et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

(2010) Awsan Noman et al.   LANCET

Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase

(2009) Hang-Korng Ea et al.   ARTHRITIS AND RHEUMATISM

Long-term Cardiovascular Mortality Among Middle-aged Men With Gout

(2008) Eswar Krishnan   ARCHIVES OF INTERNAL MEDICINE

Uric acid: A marker of increased cardiovascular risk

(2008) Ana C.M. Gagliardi et al.   ATHEROSCLEROSIS

Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension

(2008) Daniel I. Feig et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Consequences of impaired purine recycling in dopaminergic neurons

(2008) J.C. Lewers et al.   NEUROSCIENCE

Uric Acid and Cardiovascular Risk

(2008) Daniel I. Feig et al.   NEW ENGLAND JOURNAL OF MEDICINE